Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Response and microRNA Profiles in Triple Negative Breast Cancer Patients Receiving Standard Chemotherapy

NCT04771871 is registered in ClinicalTrials.gov with University College Hospital, Ibadan as lead sponsor.

NCT NCT04771871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04771871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Response and microRNA Profiles in Triple Negative Breast Cancer Patients Receiving Standard Chemotherapy
Lead sponsor
University College Hospital, Ibadan
Phase
Phase 2
Overall status
Recruiting
Start date
November 29, 2021
Completion date
August 31, 2030
Enrollment
42 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

triple negative breast cancer